Skip to content
value.today

HealthEquity, Inc.

HQY
$8.3 Bmarket cap on Oct 28, 2026+41.8% since Jan 2024
Compare
World rank
#2,473
Revenue
$1.3 B
For year ending January-2026
Net income
$215 M
16.4% margin
SEC filing
Employees
2,814
As of January 31, 2026
SEC filing

HealthEquity, Inc. in brief

HealthEquity, Inc. is a listed company in the Healthcare Information Services industry, based in Draper, Utah, USA. It was founded in 2002. Its market value was $8.3 B on 28 October 2026, which makes it the 2,473rd largest listed company in the world and the 776th largest in the USA on this site. In the year to January 2026 it had sales of $1.3 B and a net profit of $215 M, about 16 cents of profit for every dollar of sales. It employs about 2,814 people and Steve Cutler is its chief executive. Its largest product and service lines by sales in 2026 were Custodial (48%) and Interchange (15%). Its shares trade under the symbol HQY (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About HealthEquity, Inc.

HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with.

As of July 31, 2022, HealthEquity managed 7.5 million HSA accounts, plus 7 million other consumer-directed benefits ("CDBs") for total accounts of 14.5 million. Total HSA assets as of July 31, 2022 were $20.5 billion, including $13.1 billion of HSA cash and $7.4 billion of HSA investments.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

HealthEquity, Inc. timeline

7 events, 2002–2025
  1. 2002
  2. 🏁
    Founded
  3. 2008
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2014
  6. 🔔
    · approximate
    Initial public offering on Nasdaq
  7. 2018
  8. •
    Legal Entity Identifier issued
    LEI 529900LRJU1RAFQHM467 registered.
  9. 2024
  10. 💰
    Revenue passed $1 billion
    FY2024 revenue of $1.2 billion, up from $1000 million in FY2023.
  11. 2025
  12. 💰
    Record revenue of $1.3 billion
    FY2025, the highest of the 8 years on record.
  13. 💰
    Record net income of $215 million
    FY2025, the highest profit of the 6 years on record.

Events of HealthEquity, Inc. from Wikidata, SEC EDGAR, the company record, the GLEIF LEI register and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$2.4 B$4.7 B$7.1 B$9.5 B2020202120222023202420252026

World rank over time

▲ up 199 places since 2020
2020-01-01: #2675#2,67520202021-01-01: #2775#2,77520212022-01-07: #4063#4,06320222022-12-25: #2637#2,63720222023-07-30: #2713#2,71320232024-01-05: #2575#2,57520242026-08-01: #2428#2,42820262026-10-14: #2716#2,71620262026-10-28: #2476#2,4762026

Rank in USA: #873 (Jan 2020) · #929 (Jan 2021) · #1,321 (Jan 2022) · #848 (Dec 2022) · #918 (Jul 2023) · #855 (Jan 2024) · #796 (Aug 2026) · #826 (Oct 2026) · #777 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
35.3×
Price / sales (TTM)
6.1×
Price / book
4.0×
Free cash flow yield
5.5%
Net margin (TTM)
17.4%
Operating margin
24.6%
Return on equity
11.2%
Liabilities / assets
37.7%
Net debt
$638M
Revenue growth
+9.5%
R&D / revenue
20.0%
Revenue per employee
$467 K
Profit per employee
$76 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Jan 2019: revenue $287M, net income $74M$287MFY19Fiscal year ending Jan 2020: revenue $532M, net income $40M$532MFY20Fiscal year ending Jan 2021: revenue $734M, net income $9M$734MFY21Fiscal year ending Jan 2022: revenue $757M, net income $-44M$757MFY22Fiscal year ending Jan 2023: revenue $862M, net income $-26M$862MFY23Fiscal year ending Jan 2024: revenue $1000M, net income $56M$1000MFY24Fiscal year ending Jan 2025: revenue $1.2B, net income $97M$1.2BFY25Fiscal year ending Jan 2026: revenue $1.3B, net income $215M$1.3BFY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Jan 2026$1.3B+9.5%$322M$215M16.4%
Jan 2025$1.2B+20.0%$162M$97M8.1%
Jan 2024$1000M+16.0%$118M$56M5.6%
Jan 2023$862M+13.9%$9M$-26M-3.0%
Jan 2022$757M+3.1%$-24M$-44M-5.9%
Jan 2021$734M+37.9%$34M$9M1.2%
Jan 2020$532M+85.2%$77M$40M7.5%
Jan 2019$287M—$78M$74M25.7%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Jan 2026$457M$2M$455M$2.46—
Jan 2025$340M$2M$338M$1.09—
Jan 2024$243M$2M$241M$0.64—
Jan 2023$151M$3M$147M$-0.31—
Jan 2022$141M$9M$132M$-0.53—
Jan 2021$182M$13M$169M$0.12—
Jan 2020$105M$7M$98M$0.58—
Jan 2019$113M$4M$110M$1.17—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$1.4B
Net income, trailing 12 months
$236M
RevenueNet income
Three months to Oct 2024: revenue $300M, net income $6M$300MOct ’24Three months to Jan 2025 (from the annual report): revenue $312M, net income $26M$312MJan ’25Three months to Apr 2025: revenue $331M, net income $54M$331MApr ’25Three months to Jul 2025: revenue $326M, net income $60M$326MJul ’25Three months to Oct 2025: revenue $322M, net income $52M$322MOct ’25Three months to Jan 2026 (from the annual report): revenue $335M, net income $50M$335MJan ’26Three months to Apr 2026: revenue $355M, net income $69M$355MApr ’26Three months to Jul 2026: revenue $351M, net income $66M$351MJul ’26

Latest quarter to Jul 2026: revenue $351M (+7.6% on a year earlier), net income $66M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jul 2026.

Annual and quarterly reports

Premium · account

HealthEquity, Inc.'s reports from the last 8 years, from the official filing system. Downloads (Excel financial statements, PDF, the report as filed, or everything as a ZIP) are for Premium subscribers — sign in.

Annual · 8

Quarterly · 23

SEC filings

Official filings of HealthEquity, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$1.3 B
Operating income
$322 M
Net income
$215 M

For year ending January-2026 · source: SEC filing

Balance sheet

Total assets
$3.4 B
Total liabilities
$1.3 B
Total equity
$2.1 B

As of January-2026

HEALTHEQUITY - Yearly Revenue and Net Income - in Million USD

Year - EndingRevenueOperating IncomeNet Income
Jan-202386137-26 (Loss)
Jan-2022756 40-44 (Loss)
Jan-2021733808
Jan-202053110939
Jan-20192877773

Balance sheet

Total Assets as on Jan-2023 was 3,088 Million USD.

Total Liabilities as on Jan-2023 was 1,193 Million USD.

Total Equity as on Jan-2023 was 1,895 Million USD

Top 100 institutional investors in HealthEquity, Inc.#

As of Sep 30, 2026
522 institutions held 88.3 M shares (more than all shares outstanding: lent and sub-advised shares are reported by more than one filer) on Sep 30, 2026. The ten largest hold 48.8%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in HealthEquity, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.11,301,328+23,414 (+0.21%)13.66%$1000 MNov 13, 2026
2Wasatch Advisors LP7,011,469-949,266 (-11.92%)8.48%$620 MOct 13, 2026
3Vanguard Portfolio Management LLC3,951,899-105,744 (-2.61%)4.78%$350 MNov 13, 2026
4Morgan Stanley3,806,596-740,623 (-16.29%)4.60%$337 MNov 13, 2026
5Vanguard Capital Management LLC3,575,041-65,735 (-1.81%)4.32%$316 MNov 13, 2026
6State Street Corp3,242,217+1,171 (+0.04%)3.92%$287 MNov 12, 2026
7Geode Capital Management, LLC2,327,557-46,910 (-1.98%)2.81%$206 MNov 6, 2026
8Dimensional Fund Advisors LP1,896,816+27,780 (+1.49%)2.29%$168 MNov 4, 2026
9William Blair Investment Management, LLC1,740,078-33,149 (-1.87%)2.10%$154 MNov 6, 2026
10Arrowstreet Capital, Limited Partnership1,513,755+547,948 (+56.73%)1.83%$134 MNov 13, 2026
11Price T Rowe Associates Inc /MD/1,458,293+463,742 (+46.63%)1.76%$129 MNov 16, 2026
12Westfield Capital Management Co LP1,436,437+733,124 (+104.24%)1.74%$127 MNov 12, 2026
13Swedbank AB1,403,000+551,600 (+64.79%)1.70%$124 MOct 27, 2026
14Bank Of America Corp /de/1,399,811+253,076 (+22.07%)1.69%$124 MNov 16, 2026
15Goldman Sachs Group Inc1,283,552+276,118 (+27.41%)1.55%$114 MNov 16, 2026
16Brown Advisory Inc1,272,182-100,442 (-7.32%)1.54%$113 MNov 16, 2026
17Charles Schwab Investment Management Inc1,240,039+51,137 (+4.30%)1.50%$110 MNov 16, 2026
18AQR Capital Management LLC1,182,136-817,073 (-40.87%)1.43%$105 MNov 16, 2026
19Clearbridge Investments, LLC1,154,627-142,138 (-10.96%)1.40%$102 MNov 12, 2026
20FMR LLC1,152,331-386,056 (-25.09%)1.39%$102 MNov 10, 2026
21Geneva Capital Management LLC1,106,066-43,614 (-3.79%)1.34%$98 MNov 9, 2026
22Northern Trust Corp1,032,212-39,907 (-3.72%)1.25%$91 MNov 16, 2026
23Artisan Partners Limited Partnership1,026,017+641,910 (+167.12%)1.24%$91 MNov 13, 2026
24Greenhouse Funds LLLP1,002,314-180,710 (-15.28%)1.21%$89 MNov 16, 2026
25GW&K Investment Management, LLC989,427+357,045 (+56.46%)1.20%$88 MNov 10, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in HealthEquity, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Stephens Investment Management Group LLC976,998+247,918 (+34.00%)1.18%$86 MNov 10, 2026
27Loomis Sayles & Co L P963,446+54,892 (+6.04%)1.16%$85 MNov 12, 2026
28DAVENPORT & Co LLC962,799-124,419 (-11.44%)1.16%$85 MOct 14, 2026
29Jpmorgan Chase & Co887,095-271,742 (-23.45%)1.07%$78 MNov 12, 2026
30Janus Henderson Group Ltd.871,305—1.05%$77 MNov 16, 2026
31American Century Companies Inc855,483+95,505 (+12.57%)1.03%$76 MNov 12, 2026
32Nuveen, LLC748,998+16,248 (+2.22%)0.91%$66 MNov 10, 2026
33Bamco Inc /ny/700,394-50,000 (-6.66%)0.85%$62 MNov 16, 2026
34Bank of New York Mellon Corp692,832+26,572 (+3.99%)0.84%$61 MNov 5, 2026
35SEI Investments Co690,818+7,498 (+1.10%)0.84%$61 MNov 10, 2026
36Nomura Asset Management International Inc.657,982-20,555 (-3.03%)0.80%$58 MNov 16, 2026
37Vanguard Fiduciary Trust Co594,088-7,736 (-1.29%)0.72%$53 MNov 13, 2026
38UBS Group AG525,929+90,472 (+20.78%)0.64%$47 MNov 10, 2026
39Park West Asset Management LLC477,917-298,734 (-38.46%)0.58%$42 MNov 16, 2026
40Citadel Advisors LLC465,000-217,961 (-31.91%)0.56%$41 MNov 16, 2026
41Raymond James Financial Inc448,981+17,014 (+3.94%)0.54%$40 MNov 12, 2026
42Wellington Management Group LLP415,241+27,347 (+7.05%)0.50%$37 MNov 16, 2026
43Franklin Templeton Inc375,237+14,578 (+4.04%)0.45%$33 MNov 12, 2026
44Kayne Anderson Rudnick Investment Management LLC362,297-38,316 (-9.56%)0.44%$32 MNov 13, 2026
45Principal Financial Group Inc361,622+43,057 (+13.52%)0.44%$32 MNov 2, 2026
46Segall Bryant & Hamill, LLC356,341+118,098 (+49.57%)0.43%$32 MNov 16, 2026
47Oberweis Asset Management Inc/337,698+109,407 (+47.92%)0.41%$30 MNov 16, 2026
4812th Street Asset Management Company, LLC319,442-25,948 (-7.51%)0.39%$28 MNov 12, 2026
49Lazard Asset Management LLC305,607+29,914 (+10.85%)0.37%$27 MNov 16, 2026
50CIBC Bancorp USA Inc.303,650-7,745 (-2.49%)0.37%$27 MNov 13, 2026
51DF Dent & Co Inc290,244+43,112 (+17.44%)0.35%$26 MNov 16, 2026
52Point72 Asset Management, L.P.282,863New0.34%$25 MNov 16, 2026
53Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.275,817-181,105 (-39.64%)0.33%$24 MNov 12, 2026
54Aristotle Capital Boston, LLC268,343-64,541 (-19.39%)0.32%$24 MNov 16, 2026
55Portolan Capital Management, LLC265,049+175,775 (+196.89%)0.32%$23 MNov 16, 2026
56Public Sector Pension Investment Board259,970+119,018 (+84.44%)0.31%$23 MNov 10, 2026
57Rhumbline Advisers251,638-2,765 (-1.09%)0.30%$22 MNov 10, 2026
58Ashford Capital Management Inc250,446-2,995 (-1.18%)0.30%$22 MNov 16, 2026
59Barclays PLC248,409+211,966 (+581.64%)0.30%$22 MNov 6, 2026
60Envestnet Asset Management Inc230,951+55,769 (+31.83%)0.28%$20 MNov 16, 2026
61USS Investment Management Ltd230,597New0.28%$20 MNov 10, 2026
62Oppenheimer Asset Management Inc.226,704-6,674 (-2.86%)0.27%$20 MOct 27, 2026
63Ranger Investment Management, L.P.221,323-97,930 (-30.67%)0.27%$20 MNov 6, 2026
64Retirement Systems of Alabama220,184+23,906 (+12.18%)0.27%$19 MNov 4, 2026
65Allspring Global Investments Holdings, LLC219,109+16,418 (+8.10%)0.26%$19 MNov 4, 2026
66Alliancebernstein L.P.218,582-3,898 (-1.75%)0.26%$19 MNov 16, 2026
67Glenmede Trust Co NA213,697+39,830 (+22.91%)0.26%$19 MNov 16, 2026
68Royal Bank Of Canada209,161-3,103 (-1.46%)0.25%$19 MNov 16, 2026
69UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC200,848+7,356 (+3.80%)0.24%$18 MNov 16, 2026
70Invesco Ltd.196,354-1,741 (-0.88%)0.24%$17 MNov 12, 2026
71D. E. Shaw & Co., Inc.180,292+159,861 (+782.44%)0.22%$16 MNov 16, 2026
72Frontier Capital Management Co LLC173,142-11,166 (-6.06%)0.21%$15 MNov 16, 2026
73Qube Research & Technologies Ltd172,161+15,610 (+9.97%)0.21%$15 MNov 13, 2026
74Wells Fargo & Company/mn170,443-19,982 (-10.49%)0.21%$15 MNov 16, 2026
75Swiss National Bank169,100-400 (-0.24%)0.20%$15 MNov 12, 2026
76California Public Employees Retirement System150,493-4,826 (-3.11%)0.18%$13 MNov 16, 2026
77Axiom Investors LLC /de139,014+18,103 (+14.97%)0.17%$12 MNov 12, 2026
78Premier Fund Managers Ltd138,731-6,512 (-4.48%)0.17%$12 MNov 2, 2026
79Russell Investments Group, Ltd.129,582-27,204 (-17.35%)0.16%$11 MNov 6, 2026
80Castleark Management LLC129,080+1,310 (+1.03%)0.16%$11 MNov 17, 2026
81One Way Holdings LLC128,873-8,219 (-6.00%)0.16%$11 MOct 29, 2026
82Peregrine Capital Management LLC128,178-4,513 (-3.40%)0.15%$11 MNov 9, 2026
83Deutsche Bank AG\126,907-5,798 (-4.37%)0.15%$11 MNov 6, 2026
84Legal & General Group Plc122,905+4,383 (+3.70%)0.15%$11 MNov 16, 2026
85Ensign Peak Advisors, Inc116,756-525 (-0.45%)0.14%$10 MNov 12, 2026
86Prosight Management, LP115,796New0.14%$10 MNov 13, 2026
87Victory Capital Management Inc112,990+23,523 (+26.29%)0.14%$10 MNov 10, 2026
88Wealthspire Advisors, LLC110,970-1,016 (-0.91%)0.13%$10 MNov 13, 2026
89Tectonic Advisors LLC109,953+9,630 (+9.60%)0.13%$10 MOct 22, 2026
90HRT Financial LP109,455New0.13%$10 MNov 13, 2026
91Voya Investment Management LLC108,771+14,140 (+14.94%)0.13%$10 MNov 10, 2026
92Bessemer Group Inc106,777-1,911 (-1.76%)0.13%$9 MNov 9, 2026
93B. Metzler seel. Sohn & Co. AG102,322-8,786 (-7.91%)0.12%$9 MOct 30, 2026
94Ameriprise Financial Inc100,687-25,195 (-20.01%)0.12%$9 MNov 16, 2026
95Nordea Investment Management AB100,332+18,648 (+22.83%)0.12%$9 MNov 9, 2026
96Beacon Investment Advisory Services, Inc.96,556+2,319 (+2.46%)0.12%$9 MOct 13, 2026
97California State Teachers Retirement System96,070-1,724 (-1.76%)0.12%$8 MNov 13, 2026
98Renaissance Group LLC94,315-2,524 (-2.61%)0.11%$8 MNov 12, 2026
99Channing Capital Management, LLC92,409New0.11%$8 MNov 2, 2026
100Danske Bank A/s92,029New0.11%$8 MNov 9, 2026

All 522 institutional investors, with who bought and sold →

Mutual funds holding HealthEquity, Inc.#

435 funds in 2 countries hold shares worth $4.0 B (about 53.1% of the company). Since their previous reports 214 added shares and 162 sold, buying $112 M net. By country: USA 426 ($4.0 B), Sweden 9 ($86 M).
Mutual funds holding HealthEquity, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 iShares Core S&P Mid-Cap ETFBlackRock Fund Advisors2.89 M$261 M3.5%0.21%+2.2%Jun 30, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.2.52 M$228 M3.1%<0.01%−7.0%Jun 30, 2026
🇺🇸 Wasatch Core Growth FundWasatch Advisors LP2.23 M$201 M2.7%6.7%+20%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors2.18 M$197 M2.6%0.24%+5.7%Jun 30, 2026
🇺🇸 Vanguard Small-Cap Index FundThe Vanguard Group, Inc.1.82 M$165 M2.2%0.09%−7.5%Jun 30, 2026
🇺🇸 Eaton Vance Atlanta Capital SMID-Cap FundBoston Management and Research1.49 M$134 M1.8%1.5%+142%Jun 30, 2026
🇺🇸 Vanguard Small-Cap Growth Index FundThe Vanguard Group, Inc.1.05 M$95 M1.3%0.20%−4.8%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC927,272$93 M1.1%0.27%+11%Jul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.969,218$88 M1.2%0.09%+1.6%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors783,398$71 M0.95%0.46%+14%Jun 30, 2026
🇺🇸 Wasatch Small Cap Growth FundWasatch Advisors LP752,084$68 M0.91%5.8%+9.2%Jun 30, 2026
🇺🇸 Baron Small Cap FundBAMCO, Inc.750,000$68 M0.91%2.4%no changeJun 30, 2026
🇺🇸 State Street SPDR S&P MidCap 400SM ETF TrustSpdr S&P Midcap 400 ETF Trust649,983$59 M0.79%0.21%+0.9%Jun 30, 2026
🇺🇸 Small Cap Growth FundAmerican Century Investment Management, Inc.575,511$58 M0.70%1.0%+2.6%Jul 31, 2026
🇺🇸 ClearBridge Select FundFRANKLIN TEMPLETON FUND ADVISER, LLC488,386$49 M0.59%1.5%−6.6%Jul 31, 2026
🇺🇸 Vanguard Explorer FundThe Vanguard Group, Inc.476,716$48 M0.58%0.22%+15%Jul 31, 2026
🇺🇸 iShares S&P Mid-Cap 400 Growth ETFBlackRock Fund Advisors505,806$46 M0.61%0.40%−2.7%Jun 30, 2026
🇺🇸 T. Rowe Price Integrated U.S. Small-Cap Growth Equity FundT. Rowe Price Associates, Inc.449,983$41 M0.54%0.41%no changeJun 30, 2026
🇸🇪 Swedbank Robur Transfer 70Swedbank Robur Fonder AB437,300$39 M0.53%0.34%no changeJun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC439,329$39 M0.53%0.09%−3.0%May 31, 2026
🇺🇸 State Street SPDR Portfolio S&P 400 Mid Cap ETFSSGA Funds Management, Inc.427,626$39 M0.52%0.21%+2.5%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.433,127$38 M0.52%0.22%+2.4%May 31, 2026
🇺🇸 Janus Henderson Triton FundJanus Investment Fund418,746$38 M0.51%0.64%+1.7%Jun 30, 2026
🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC416,088$38 M0.50%0.65%+12%Jun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP367,698$37 M0.44%0.19%no changeJul 31, 2026
🇺🇸 Wasatch Small Cap Value FundWasatch Advisors LP405,271$37 M0.49%2.6%+1.3%Jun 30, 2026
🇺🇸 ClearBridge Small Cap Growth FundFRANKLIN TEMPLETON FUND ADVISER, LLC360,320$36 M0.44%1.9%no changeJul 31, 2026
🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc.410,182$36 M0.50%0.16%−2.0%May 31, 2026
🇺🇸 Harbor Small Cap Growth FundHarbor Capital Advisors, Inc.346,177$35 M0.42%1.3%+5.8%Jul 31, 2026
🇺🇸 JPMorgan Small Cap Equity FundJ.P. Morgan Investment Management Inc.368,976$33 M0.45%1.2%−7.6%Jun 30, 2026
🇺🇸 Franklin Small Cap Growth FundFranklin Advisers, Inc.308,622$31 M0.37%1.3%+5.6%Jul 31, 2026
🇺🇸 Davenport Equity Opportunities FundDavenport & Company LLC310,310$28 M0.38%3.5%+13%Jun 30, 2026
🇺🇸 Davenport Small Cap Focus FundDavenport & Company LLC304,228$27 M0.37%4.4%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP270,563$27 M0.33%0.18%+3.4%Jul 31, 2026
🇺🇸 Nomura Small Cap Core FundDelaware Management Company292,177$26 M0.35%0.47%−4.1%May 29, 2026
🇸🇪 Swedbank Robur Transfer 80Swedbank Robur Fonder AB269,000$24 M0.33%0.21%no changeJun 30, 2026
🇺🇸 Fidelity Small Cap Growth FundFidelity Management & Research Company LLC235,933$24 M0.29%0.27%no changeJul 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC255,125$23 M0.31%0.02%no changeJun 30, 2026
🇺🇸 Nationwide Geneva Small Cap Growth FundNATIONWIDE FUND ADVISORS227,629$23 M0.28%2.6%−12%Jul 31, 2026
🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc.256,670$23 M0.31%0.12%−0.8%May 31, 2026
🇺🇸 Loomis Sayles Small Cap Growth FundLoomis, Sayles & Company, L.P.245,432$22 M0.30%0.98%−9.7%Jun 30, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC208,666$21 M0.25%0.85%+4.5%Jul 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.206,104$21 M0.25%0.27%+11%Jul 31, 2026
🇺🇸 Schwab U.S. Mid-Cap ETFCharles Schwab Investment Management, Inc.230,781$20 M0.28%0.14%−1.0%May 31, 2026
🇺🇸 Wasatch Ultra Growth FundWasatch Advisors LP224,032$20 M0.27%4.4%no changeJun 30, 2026
🇺🇸 Morgan Stanley Discovery PortfolioBrighthouse Investment Advisers, LLC221,210$20 M0.27%1.6%+13%Jun 30, 2026
🇺🇸 Janus Henderson Venture FundJanus Investment Fund215,922$20 M0.26%0.54%+3.6%Jun 30, 2026
🇺🇸 Brown Advisory Small-Cap Growth FundBROWN ADVISORY LLC214,956$19 M0.26%3.3%−4.2%Jun 30, 2026
🇺🇸 JNL Multi-Manager Small Cap Growth FundJackson National Asset Management, LLC204,688$18 M0.25%0.73%−34%Jun 30, 2026
🇺🇸 AQR Long-Short Equity FundAQR CAPITAL MANAGEMENT, LLC203,143$18 M0.25%0.23%−45%Jun 30, 2026
🇺🇸 Oberweis Small-Cap Opportunities FundOberweis Asset Management, Inc.194,200$18 M0.23%0.62%+40%Jun 30, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC196,608$17 M0.24%0.02%+3.1%May 31, 2026
🇺🇸 Fidelity Stock Selector Small Cap FundFidelity Management & Research Company LLC151,100$15 M0.18%0.21%+15%Jul 31, 2026
🇺🇸 Small Cap Equity PortfolioGlenmede Investment Management LP149,101$15 M0.18%1.4%−5.5%Jul 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP149,037$15 M0.18%0.03%+2.4%Jul 31, 2026
🇺🇸 William Blair Small Cap Growth FundWilliam Blair Investment Management, LLC163,750$15 M0.20%1.2%+46%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC161,294$14 M0.19%0.01%no changeMay 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC156,460$14 M0.19%0.24%+14%Jun 30, 2026
🇺🇸 William Blair Small-Mid Cap Growth FundWilliam Blair Investment Management, LLC155,800$14 M0.19%1.1%−0.6%Jun 30, 2026
🇺🇸 iShares U.S. Healthcare Providers ETFBlackRock Fund Advisors148,817$13 M0.18%1.1%+48%Jun 30, 2026
🇺🇸 Nomura Small Cap Growth FundDelaware Management Company146,690$13 M0.18%1.1%+22%Jun 30, 2026
🇺🇸 Discovery PortfolioMorgan Stanley Investment Management Inc.146,577$13 M0.18%1.7%+12%Jun 30, 2026
🇺🇸 JPMorgan Small Cap Growth FundJ.P. Morgan Investment Management Inc.138,042$12 M0.17%0.48%−5.0%Jun 30, 2026
🇺🇸 Fidelity Small Cap Growth K6 FundFidelity Management & Research Company LLC119,638$12 M0.14%0.26%no changeJul 31, 2026
🇺🇸 Vanguard S&P Mid-Cap 400 Index FundThe Vanguard Group, Inc.136,309$12 M0.16%0.21%+3.9%May 31, 2026
🇺🇸 State Street SPDR S & P 400 Mid Cap Growth ETFSSGA Funds Management, Inc.130,609$12 M0.16%0.40%+0.4%Jun 30, 2026
🇺🇸 Virtus KAR Mid-Cap Growth FundVirtus Equity Trust127,212$11 M0.15%2.8%−9.6%Jun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC130,285$11 M0.16%0.01%+2.3%May 31, 2026
🇺🇸 AMG GW&K Small Cap Core FundAMG Funds LLC123,535$11 M0.15%1.4%+53%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC110,689$11 M0.13%0.27%+11%Jul 31, 2026
🇺🇸 Artisan Small Cap FundArtisan Partners Limited Partnership122,416$11 M0.15%1.2%+39%Jun 30, 2026
🇺🇸 Principal U.S. Small-Cap ETFPrincipal Global Investors, LLC119,817$11 M0.14%0.46%+9.5%Jun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC118,455$11 M0.14%2.3%+14%Jun 30, 2026
🇺🇸 Old Westbury Small & Mid Cap Strategies FundBessemer Investment Management LLC105,925$11 M0.13%0.12%−41%Jul 31, 2026
🇺🇸 Inception PortfolioMorgan Stanley Investment Management Inc.112,651$10 M0.14%3.6%+16%Jun 30, 2026
🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors110,811$10 M0.13%0.01%−0.3%Jun 30, 2026
🇺🇸 ClearBridge Small Cap FundFRANKLIN TEMPLETON FUND ADVISER, LLC99,465$10 M0.12%1.4%no changeJul 31, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP97,220$10 M0.12%0.03%no changeJul 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC106,276$10 M0.13%0.09%+4.8%Jun 30, 2026
🇺🇸 NYLIM VP Small Cap Growth PortfolioNew York Life Investment Management LLC103,433$9 M0.13%2.2%+1.3%Jun 30, 2026
🇺🇸 Fidelity Series Small Cap Opportunities FundFidelity Management & Research Company LLC86,700$9 M0.10%0.18%−11%Jul 31, 2026
🇺🇸 Strategic Advisers Fidelity U.S. Total Stock FundStrategic Advisers LLC98,513$9 M0.12%<0.01%no changeMay 31, 2026
🇺🇸 Applied Finance Explorer FundApplied Finance Advisors, LLC85,707$9 M0.10%0.82%newJul 31, 2026
🇺🇸 Dimensional U.S. Targeted Value ETFDimensional Fund Advisors LP85,269$9 M0.10%0.06%+188%Jul 31, 2026
🇺🇸 Morningstar U.S. Equity FundMorningstar Investment Management LLC84,154$8 M0.10%0.44%+25%Jul 31, 2026
🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC95,272$8 M0.12%0.16%+119%May 29, 2026
🇺🇸 U.S. Targeted Value PortfolioDimensional Fund Advisors LP83,089$8 M0.10%0.05%+139%Jul 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC92,092$8 M0.11%0.22%+4.6%Jun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC79,518$8 M0.10%0.01%+7.8%Jul 31, 2026
🇺🇸 Allspring Common Stock FundAllspring Funds Management, LLC87,671$8 M0.11%1.2%−22%Jun 30, 2026
🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP78,247$8 M0.09%0.02%no changeJul 31, 2026
🇺🇸 JNL Mid Cap Index FundJackson National Asset Management, LLC85,708$8 M0.10%0.21%−0.2%Jun 30, 2026
🇺🇸 AQR Equity Market Neutral FundAQR CAPITAL MANAGEMENT, LLC83,988$8 M0.10%0.26%−33%Jun 30, 2026
🇺🇸 Vanguard S&P Mid-Cap 400 Growth Index FundThe Vanguard Group, Inc.85,672$8 M0.10%0.41%+9.0%May 31, 2026
🇺🇸 Nationwide Geneva Mid Cap Growth FundNATIONWIDE FUND ADVISORS73,159$7 M0.09%2.8%+30%Jul 31, 2026
🇺🇸 Dimensional U.S. Marketwide Value ETFDimensional Fund Advisors LP72,205$7 M0.09%0.05%+0.7%Jul 31, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC79,524$7 M0.10%0.46%+24%Jun 30, 2026
🇺🇸 ClearBridge Variable Small Cap Growth PortfolioFRANKLIN TEMPLETON FUND ADVISER, LLC78,332$7 M0.09%1.5%+2.4%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.79,126$7 M0.10%0.41%+1.2%May 31, 2026
🇺🇸 Fidelity Enhanced Large Cap Core ETFFidelity Management & Research Company LLC76,575$7 M0.09%0.09%+957088%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at HealthEquity, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$12 K
2 purchases, 1 insider
Sold, 12 months
$4.2 M
13 sales, 6 insiders
Net, 12 months
-$4.2 M
open market only
Insiders on file
44
since
$10 K-$34.0 M$0Dec 2023: bought $0 (0 trades), sold $7.8 M (5 trades)Dec 23Jan 2024: bought $0 (0 trades), sold $181 K (1 trades)Feb 2024: bought $0 (0 trades), sold $200 K (1 trades)Mar 2024: bought $0 (0 trades), sold $5.5 M (3 trades)MarJun 2024: bought $0 (0 trades), sold $7.6 M (10 trades)Jul 2024: bought $0 (0 trades), sold $3.9 M (5 trades)Sep 2024: bought $0 (0 trades), sold $3.3 M (5 trades)SepOct 2024: bought $0 (0 trades), sold $785 K (6 trades)Nov 2024: bought $0 (0 trades), sold $100 K (1 trades)Dec 2024: bought $0 (0 trades), sold $4.0 M (6 trades)DecFeb 2025: bought $0 (0 trades), sold $640 K (2 trades)Apr 2025: bought $0 (0 trades), sold $1.1 M (4 trades)Jun 2025: bought $0 (0 trades), sold $34.0 M (11 trades)JunJul 2025: bought $0 (0 trades), sold $183 K (2 trades)Sep 2025: bought $0 (0 trades), sold $888 K (4 trades)Oct 2025: bought $0 (0 trades), sold $295 K (2 trades)OctNov 2025: bought $0 (0 trades), sold $157 K (1 trades)Dec 2025: bought $0 (0 trades), sold $1.6 M (3 trades)Apr 2026: bought $0 (0 trades), sold $2 K (1 trades)AprMay 2026: bought $0 (0 trades), sold $1.2 M (3 trades)Jul 2026: bought $2 K (1 trades), sold $458 K (2 trades)Aug 2026: bought $0 (0 trades), sold $810 K (3 trades)AugOct 2026: bought $10 K (1 trades), sold $0 (0 trades)
Bought (open market)Sold (open market)Hover a month for the totals
HealthEquity, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Sunil RajasekarEVP Chief Prod & Strat OfficerBuy+108$90.33$10 K53,405Form 4
filed Stephen NeelemanFOUNDER AND VICE CHAIRMAN, DirectorShares withheld for tax-1,095$91.16$100 K136,470Form 4
filed James M. LucaniaEVP & CFOShares withheld for tax-2,822$91.16$257 K101,795Form 4
filed Delano LaddEVP, General CounselShares withheld for tax-1,080$91.16$98 K88,974Form 4
filed Scott CutlerPresident and CEO, DirectorShares withheld for tax-1,230$91.16$112 K175,175Form 4
filed Michael Henry FioreFormer EVP, CCOShares withheld for tax-2,032$91.16$185 K50,212Form 4
filed Michael GathrightChief Customer OfficerShares withheld for tax-662$91.16$60 K39,231Form 4
filed Stephen NeelemanFOUNDER AND VICE CHAIRMAN, DirectorGiftindirect-1,500——408,235Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: HealthEquity, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
5.5 M
6.4% of shares · 7.55 days to cover
Buybacks, Q3 2026
$107.7M
Q2 2027
Shares sold short, last 24 reportsAll stocks →
HealthEquity, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2026Q2 2027$107.7M
Q2 2026Q1 2027$123.3M
Q1 2026Q4 2026$81M
Q4 2025Q3 2026$92.4M
Q3 2025Q2 2026$66.7M
Q2 2025Q1 2026$59.1M
Q1 2025Q4 2025$63M
Q4 2024Q3 2025$58.5M
Q3 2024Q2 2026$0M
Q2 2024Q1 2026$0M
Q1 2024Q4 2025$0M

Fails to deliver

  • : 1,124 shares at $100.88
  • : 18,561 shares at $103.97
  • : 536 shares at $96.60
  • : 6,039 shares at $90.19
  • : 67 shares at $91.90

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

HealthEquity, Inc. scorecard#

Passes 19 of the 26 checks that could be worked out: strongest in growth (6 of 6), weakest in valuation (2 of 6). Fiscal year 2025; market cap of Oct 28, 2026.

  • Valuation2 of 6
    • ✗P/E below its peers' median35.3×P/E 35.3× against Healthcare's median of 30.0×.
    • ✗Price to book below its peers' median4.0×Price to book 4.0× against Healthcare Information Services's median of 1.9×.
    • ✗Price to sales below its peers' median6.1×Price to sales 6.1× against Healthcare Information Services's median of 1.7×.
    • ✓Free cash flow yield above 5%5.5%Free cash flow is 5.5% of the market value.
    • ✗Earnings yield above the 10-year Treasury yield2.8%Earnings yield 2.8% against the 10-year Treasury's 5.15% on 2026-11-13.
    • ✓The price assumes slower growth than the last three years'11.6%The price assumes 11.6% a year for ten years; revenue grew 15.1% a year over the last three.
  • Growth6 of 6
    • ✓Revenue grew in the newest year9.5%Revenue up 9.5% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years15.1%15.1% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median15.1%15.1% a year against Healthcare Information Services's median of 6.1% (27 companies).
    • ✓Earnings per share grew in the newest year2.46 vs 1.09Diluted EPS 2.46 in fiscal 2025 against 1.09 the year before (report's currency).
    • ✓Net income higher than five years earlier$215 M$215 M in fiscal 2025 against $9 M in 2020.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
  • Profitability3 of 6
    • ✓Profitable in the newest year$215 MNet income $215 M in fiscal 2025.
    • ✗Profitable in each of the last five years3 of 5Profitable in 3 of the five years to fiscal 2025.
    • ✓Operating margin above its peers' median24.6%24.6% against Healthcare Information Services's median of -7.1% (29 companies).
    • ✗Return on equity above 15%10.2%10.2% in fiscal 2025.
    • ✗Return on invested capital above 10%8.9%8.9% in fiscal 2025.
    • ✓Operating margin wider than three years earlier24.6%24.6% in fiscal 2025 against 1.1% in 2022.
  • Financial health5 of 5
    • ✓Short-term assets cover short-term liabilities3.3×Current ratio 3.27 at the end of fiscal 2025.
    • ✓Debt below equity0.5×Debt to equity 0.45 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDA1.3×Net debt 1.3 times EBITDA in fiscal 2025.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone4.84Z-score 4.84 (safe zone) for fiscal 2025.
  • Shareholder returns3 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year-1.5%Diluted shares down 1.5% in fiscal 2025.
    • ✓Dividends and buybacks above 3% of the market value3.6%Dividends and buybacks were 3.6% of the market value.
    • ✓Free cash flow covers dividends and buybacks$455 MFree cash flow $455 M against $299 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Healthcare Information Services, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from HealthEquity, Inc.'s statements, beside the median of Healthcare Information Services.

HealthEquity, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin24.6%-7.1%
Net margin16.4%-6.8%
Return on equity10.2%-0.8%
Revenue growth, 3 years a year15.1%6.1%
Revenue growth9.5%8.7%
Debt to equity0.45×0.62×

9of 9on the Piotroski tests of financial strength

  • Goodwill and intangibles ($2.7 billion) exceed shareholders' equity ($2.1 billion).
  • Revenue has grown 13 years in a row.
  • Free cash flow has been positive 14 years in a row.

HealthEquity, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

HealthEquity, Inc.: statements by fiscal year
PeriodTrendFY 2025to Jan 31, 2026FY 2024to Jan 31, 2025FY 2023to Jan 31, 2024FY 2022to Jan 31, 2023FY 2021to Jan 31, 2022FY 2020to Jan 31, 2021FY 2019to Jan 31, 2020FY 2018to Jan 31, 2019FY 2017to Jan 31, 2018FY 2016to Jan 31, 2017
Income statement
Revenue1,3131,2001,000862757734532287230178
Cost of revenue400423377370r332r3182061069572
Gross profit913777623492r425r415326181135106
Research and development26324021919315712578352722
Selling and marketing95917969595044292318
General and administrative12013210497r85r8461332520
Operating expenses591615505483r449r3812491048065
Operating income3221621189.1−243477785441
Interest expense and finance costs576155483735250.30.3—
Other non-operating income (expense)−45−46−43−47−43−30−34−1.9−2.2−1.1
Income before tax27711675−38−674.143765240
Income tax621919−12−22−4.73.51.94.814
Net income attributable to shareholders2159756−26−448.840744726
Earnings per share, basic2.501.110.65-0.31-0.530.120.591.200.790.45
Earnings per share, diluted2.461.090.64-0.31-0.530.120.581.170.770.44
Shares, weighted average (basic)86878684837467626059
Shares, weighted average (diluted)87898784837668636260
Balance sheet
Cash and cash equivalents319296404254225329192361199140
Receivables12411810597877371262217
Inventory————————0.20.6
Other current assets706449323859357.53.5r2.9
Current assets512478557383351460297395265201
Property, plant and equipment3.23.26.0132329338.27.85.2
Right-of-use (leased) assets36434856649083———
Goodwill1,6481,6481,6481,6481,6461,3271,3334.74.74.7
Other intangible assets1,0971,205836936973767783808465
Investments in associates———————0.2——
Long-term investments———————0.7——
Total assets3,3803,4493,1643,0893,1072,7102,565510369279
Accounts payable12141214281.64.03.52.43.2
Debt due within a year000188.863390——
Current liabilities157156117131153205152292016
Long-term debt9571,0568759089229241,1820——
Lease liabilities (non-current)34424959657468———
Non-current liabilities1,1161,1771,0121,0621,1011,1271,3833.92.41.5
Total liabilities1,2731,3341,1291,1931,2551,3321,535332317
Retained earnings1962092061501762202121728530
Shareholders' equity2,1072,1152,0351,8961,8531,3791,030477346262
Total liabilities and equity3,3803,4493,1643,0893,1072,7102,565510369279
Shares outstanding85878685847771626160
Cash-flow statement
Depreciation and amortization15516215316113711655181613
Share-based compensation7396776353434021148.4
Cash from operating activities4573402431511411821051138246
Capital expenditure−2.0−2.1−1.7−3.4−8.9−13−7.3−3.9−5.5−3.6
Intangible assets bought−0.3−452−3.3−71−65−32−9.1−1.2−180
Acquisitions, net of cash acquired——00−5050−1,6450−2.9—
Cash from investing activities−47−505−46−119−639−97−1,74026−37−13
Debt issued07370095001,25000—
Debt repaid−100−562−54−8.8−1,003−239−7.800—
Shares issued——0045728745800—
Shares bought back−299−12100——————
Dividends paid—————————0
Cash from financing activities−38758−47−2.7395521,466231524
Change in cash23−10815029−103137−1701626056
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Jul 31, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What HealthEquity, Inc. sells: revenue by product line, fiscal 2026#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2025. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Custodial$637 M48%
  • Service(total)$485 M37%
  • Interchange$192 M15%

Source: SEC annual report (XBRL data) · as of Jan 31, 2026

Where HealthEquity, Inc. operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for HealthEquity, Inc.: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

HealthEquity, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters2 offices—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at HealthEquity, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2026
$13.6 M
Scott Cutler
Other top executives, average
$4.4 M
the CEO earned 3.1× this
$100 invested is now
$103
peer group: $81
HealthEquity, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2026Scott Cutler$13.6 M$10.4 M$4.4 M$103 (peers $81)
2025Jon Kessler, Scott Cutler$12.6 M$36.8 M$5.0 M$132 (peers $102)
2024Jon Kessler$13.4 M$22.9 M$3.9 M$90 (peers $76)
2023Jon Kessler$13.4 M$14.4 M$5.6 M$73 (peers $73)
2022Jon Kessler$9.9 M−$5.5 M$2.4 M$64 (peers $93)

Source: SEC proxy statement (Form DEF 14A) · as of Jan 31, 2026

Events at HealthEquity, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 8 · Material agreement 2 · Agreement ended 1 · New debt 1 · Shareholder vote 3 · Results announced 12

HealthEquity, Inc.: events reported to the SEC
FiledWhat happenedFiling
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Results announced8-K
Material agreement8-K
Directors and officers8-K
Results announced8-K
Material agreementAgreement endedNew debt8-K
Directors and officersShareholder vote8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Oct 9, 2026

Acquisitions and funding#

Private share sales · funding history

Private share sales of HealthEquity, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2011$13 MIssued in a merger or acquisition$10 to $50 million2equity, debt, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Government contracts: HealthEquity, Inc.#

$26.9 M in federal contracts in fiscal 2026, mostly from Office of Personnel Management and Department of Veterans Affairs.

Contracts, FY2026
$26.9 M
#233 among companies on value.today
Grants, FY2026
—
FY2027 to date
$350
contracts and grants
Since FY2008
$102.3 M
contracts and grants
  • Office of Personnel Management$23.0 M
  • Department of Veterans Affairs$2.7 M
  • Department of Defense$550 K
  • Department of Homeland Security$188 K
  • Consumer Financial Protection Bureau$61 K
  • Department of Health and Human Services$60 K
HealthEquity, Inc.: federal obligations by fiscal year
Fiscal yearContractsGrants
FY2027 (to date)$350—
FY2026$26.9 M—
FY2025$21.0 M—
FY2024$18.5 M—
FY2023$15.9 M—
FY2022$9.9 M—
FY2021$9.7 M—
FY2020$422 K—

Source: USAspending.gov. Obligations are binding promises to pay, not payments, and can be negative when an award is cut. Counted under HealthEquity, Inc.: HEALTHEQUITY, INC. (UEI JHYDEGZ72RH3)

Lobbying by HealthEquity, Inc.#

$3.2 M spent on lobbying the US Congress and federal agencies in 2025, most often on health issues and taxation/internal revenue code.

Lobbying, 2025
$3.2 M
#137 among companies on value.today
Own lobbyists
Yes
files its own reports
Firms hired
5
in 2025
2026 so far
$1.8 M
  • Health Issues18 reports
  • Taxation/Internal Revenue Code12 reports

Lobbying firms hired in 2025

BOCKORNY GROUP, INC. $185 K · Tarplin, Downs & Young, LLC $160 K · Groom Law Group, Chartered $80 K · ACTUM I, LLC $60 K · Federal Policy Group, LLC $60 K

The firms' fees are part of HealthEquity, Inc.'s own reported expenses, so they are not added again.

HealthEquity, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2026 (so far)$1.8 M$1.8 M12
2025$3.2 M$3.2 M19
2024$2.8 M$2.8 M20
2023$1.7 M$1.7 M14
2022$770 K$700 K8
2021$220 K—7
2020$250 K—6
2019$280 K—5

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “HealthEquity fka as Wage Works”, “HealthEquity” and “HealthEquity, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

H-1B hiring at HealthEquity, Inc.#

14 labor condition applications certified in fiscal 2026 for 14 positions, at a median wage of $157 K a year.

Certified, FY2026
14
#697 among companies on value.today
Worker positions
14
Median wage offered
$157 K
a year, full-time
Applications filed
15
HealthEquity, Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Senior Software EngineerSoftware Developers4$160 K
Sr. Applications DeveloperSoftware Developers2$136 K
Sr. Software EngineerSoftware Developers2$162 K
Application Integration SpecialistSoftware Developers1$140 K
CRM Data AnalystBusiness Intelligence Analysts1$95 K
Director of Software EngineeringComputer and Information Systems Managers1$215 K
Senior Platform EngineerSoftware Developers1$159 K
Senior Site Reliability EngineerSoftware Developers1$141 K
Sr. Site Reliability EngineerSoftware Developers1$133 K

Where: Zephyrhills, FL 2 · Fremont, CA 2 · Chesterfield, MO 1 · Gilroy, CA 1 · Plainsboro, NJ 1 · Tampa, FL 1 · Leander, TX 1 · Wesley Chapel, FL 1

HealthEquity, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY20261414$157 K15
FY20251515$155 K15
FY202488$139 K8
FY20233131$145 K31
FY202233$78 K3
FY202122$96 K2
FY202022$61 K2

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as HealthEquity, Inc.

Discuss HealthEquity, Inc.#

2 automatic updates and 0 member comments. Sign in to comment and react.

  • Insider trading in October 2026automatic update · Oct 31, 2026

    Directors and officers of HealthEquity, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 1 insider bought shares worth about $9,756 in 1 trade. Awards, option exercises and shares withheld for tax are not counted.

  • Mutual funds: 435 funds hold $4.0 billionautomatic update · Jul 31, 2026

    435 mutual funds in 2 countries hold shares of HealthEquity, Inc. worth $4.0 billion, about 53.1% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 214 funds added shares and 162 sold; on balance they bought $112 million. Share splits are not counted as trading.

How HealthEquity, Inc. compares in Healthcare Information Services

  • Market cap$8.3 B · higher than 92% of 37
  • Revenue$1.3 B · higher than 84% of 70
  • Net margin17.4% · higher than 90% of 68
  • Revenue growth9.5% · higher than 54% of 38
  • P/E ratio35.3× · lower than 81% of 17
  • Price / sales6.1× · lower than 33% of 28
  • Price / book4.0× · lower than 30% of 28
  • FCF yield5.5% · higher than 60% of 21

Peer comparison · Healthcare Information Services

CompanyMarket capP/ENet marginRev. growth
HealthEquity, Inc.🇺🇸$8.3 B35.3×17.4%+9.5%
Veeva Systems Inc.🇺🇸$50.2 B49.5×29.4%+16.3%
Pro Medicus Limited🇦🇺$14.4 B81.3×——
10x Genomics, Inc.🇺🇸$9.4 B—-10.8%+5.3%
M3, Inc.🇯🇵$7.1 B21.5×14.0%—
Doximity, Inc.🇺🇸$5.5 B39.5×21.1%+13.1%
Privia Health Group, Inc.🇺🇸$2.8 B80.9×1.4%+22.3%
Winning Health Technology Group Co., Ltd.🇨🇳$2.3 B41.3×13.8%—
Progyny, Inc.🇺🇸$2.1 B23.1×6.8%+10.4%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 28, 2026
Annual results:
For year ending January-2026
Balance sheet:
As of January-2026
Employees:
As of January 31, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, Wikipedia, Wikidata, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at HealthEquity, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show HealthEquity, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about HealthEquity, Inc.? Suggest a correction